10% OFF SITEWIDE

00h00m00s
use codeAUGUST10stacks on top of bundle savings
side-by-side research comparison

5-Amino-1MQ vs GLP-3 RTA

5-Amino-1MQ and GLP-3 RTA are both studied in weight research, but they are different classes of compound with different reported research applications.

✓ both US-made · third-party tested · batch COA on every order

at a glance

5-Amino-1MQGLP-3 RTA
compound classSmall-molecule enzyme inhibitor (not a peptide)Synthetic triple-agonist peptide
research areaweight & metabolicweight & metabolic
purity standard99%+ by HPLC99%+ by HPLC
manufacturedUnited StatesUnited States
batch COApublished per lotpublished per lot
price from$124.99$155.99
availabilityin stockin stock

what each one is

5-Amino-1MQ

Small-molecule enzyme inhibitor (not a peptide)

5-Amino-1MQ is a small molecule rather than a peptide: a methylquinolinium compound that acts as a selective inhibitor of nicotinamide N-methyltransferase (NNMT). It is cell-permeable and carries a permanent positive charge on its quaternary nitrogen, a structural feature that shapes how it distributes in cellular assays and why it is used as a tool compound in enzyme-inhibition research.

full 5-Amino-1MQ profile →

GLP-3 RTA

Synthetic triple-agonist peptide

GLP-3 RTA is a synthetic single-chain peptide engineered to act at three related class B G-protein-coupled receptors at once: the GLP-1 receptor, the GIP receptor, and the glucagon receptor. Its backbone is derived from the incretin peptide family and carries a fatty-acid modification that extends plasma half-life in pre-clinical systems, making it a widely cited reference agonist in incretin-receptor research.

full GLP-3 RTA profile →

where the research differs

Both compounds are supplied strictly for laboratory research use only. Reported research contexts for each:

5-Amino-1MQ

  • NNMT enzyme-inhibition and kinetics research
  • NAD+ salvage-pathway and nicotinamide-metabolism studies
  • S-adenosylmethionine and methyl-donor balance research
  • Adipocyte and cellular energy-metabolism research models
  • Small-molecule structure–activity and selectivity studies

GLP-3 RTA

  • GLP-1, GIP, and glucagon receptor agonism research
  • cAMP and class B GPCR signaling research models
  • Comparative single-, dual-, and triple-agonist pharmacology studies
  • Metabolic-pathway and nutrient-handling research models
  • Peptide half-life, lipidation, and stability research

shop either compound

Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.

build a stack with both →

frequently asked

What is 5-Amino-1MQ?

5-Amino-1MQ is a small molecule, not a peptide — a methylquinolinium compound that selectively inhibits the enzyme nicotinamide N-methyltransferase (NNMT). Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

Is 5-Amino-1MQ a peptide?

No. It is a small-molecule enzyme inhibitor with no amino-acid backbone, which is why it is handled and stored differently from the peptides in the catalog. It is supplied strictly for laboratory research.

What is GLP-3 RTA?

GLP-3 RTA is a synthetic peptide that acts as an agonist at three receptors — GLP-1, GIP, and glucagon. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is GLP-3 RTA studied for in research?

In in-vitro and pre-clinical models it is used as a reference agonist in incretin-receptor pharmacology, cAMP signaling, and metabolic-pathway research. Verve makes no claims about use in humans or animals.

related comparisons

verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.